Lymphocyte-Mediated Immune Regulation in Health and Disease: The Treg and γδ T Cell Co-Conspiracy

di Payne, Kyle K.
Pubblicato in Immunol Invest (2016)

Cancer immunotherapy: Re-programming cells of the innate and adaptive immune systems

di Manjili, Masoud H., Payne, Kyle K.
Pubblicazione 2012

Estrogens drive myeloid-derived suppressor cell accumulation

di Conejo-Garcia, Jose R., Payne, Kyle K., Svoronos, Nikolaos
Pubblicato in Oncoscience (2017)

HLA-DR expression on myeloid cells is a potential prognostic factor in patients with high-risk neuroblastoma

di Gowda, Madhu, Payne, Kyle K, Godder, Kamar, Manjili, Masoud H
Pubblicazione 2013

IFN-γ Rα Is a Key Determinant of CD8+ T Cell-Mediated Tumor Elimination or Tumor Escape and Relapse in FVB Mouse

di Kmieciak, Maciej, Payne, Kyle K., Wang, Xiang-Yang, Manjili, Masoud H.
Pubblicazione 2013

Immunotherapy of Cancer: Reprogramming Tumor-Immune Crosstalk

di Payne, Kyle K., Toor, Amir A., Wang, Xiang-Yang, Manjili, Masoud H.
Pubblicazione 2012

IFN-γ orchestrates tumor elimination, tumor dormancy, tumor escape and progression

di Aqbi, Hussein F., Wallace, Matthew, Sappal, Samay, Payne, Kyle K, Manjili, Masoud H
Pubblicato in J Leukoc Biol (2018)

Conditioning neoadjuvant therapies for improved immunotherapy of cancer

di Benson, Zachary, Manjili, Saeed H., Habibi, Mehran, Guruli, Georgi, Toor, Amir A, Payne, Kyle K., Manjili, Masoud H.
Pubblicato in Biochem Pharmacol (2017)

Immunotherapy for Breast Cancer: Current and Future Strategies

di Williams, Austin D., Payne, Kyle K., Posey, Avery D., Hill, Christine, Conejo-Garcia, Jose, June, Carl H., Tchou, Julia
Pubblicato in Curr Surg Rep (2017)

DNA methyltransferase inhibition increases efficacy of adoptive cellular immunotherapy of murine breast cancer

di Terracina, Krista P., Graham, Laura J., Payne, Kyle K., Manjili, Masoud H., Baek, Annabel, Damle, Sheela R., Bear, Harry D.
Pubblicato in Cancer Immunol Immunother (2016)

Activated NK T cells and NK cells render T cells resistant to MDSC and result in an effective adoptive cellular therapy against breast cancer in the FVBN202 transgenic mouse

di Kmieciak, Maciej, Basu, Debasmita, Payne, Kyle K, Toor, Amir, Yacoub, Adly, Wang, Xiang-Yang, Smith, Lisa, Bear, Harry D, Manjili, Masoud H
Pubblicazione 2011

Coordinated Upregulation of Mitochondrial Biogenesis and Autophagy in Breast Cancer Cells: The Role of Dynamin Related Protein-1 and Implication for Breast Cancer Treatment

di Zou, Peng, Liu, Longhua, Zheng, Louise D., Payne, Kyle K., Manjili, Masoud H., Idowu, Michael O., Zhang, Jinfeng, Schmelz, Eva M., Cheng, Zhiyong
Pubblicato in Oxid Med Cell Longev (2016)

Peripheral blood mononuclear cells of breast cancer patients can be reprogrammed to enhance anti-HER-2/neu reactivity and overcome myeloid-derived suppressor cells

di Payne, Kyle K, Zoon, Christine K, Wan, Wen, Marlar, Khin, Keim, Rebecca C, Kenari, Mehrab Nasiri, Kazim, Latif, Bear, Harry D, Manjili, Masoud H
Pubblicazione 2013

Peripheral blood mononuclear cells of patients with breast cancer can be reprogrammed to enhance anti-HER-2/neu reactivity and overcome myeloid-derived suppressor cells

di Payne, Kyle K, Zoon, Christine K, Wan, Wen, Marlar, Khin, Keim, Rebecca C, Kenari, Mehrab Nasiri, Kazim, A Latif, Bear, Harry D, Manjili, Masoud H
Pubblicato in Breast Cancer Res Treat (2013)

Tumor-reactive immune cells protect against metastatic tumor and induce immunoediting of indolent but not quiescent tumor cells

di Payne, Kyle K., Keim, Rebecca C., Graham, Laura, Idowu, Michael O., Wan, Wen, Wang, Xiang-Yang, Toor, Amir A., Bear, Harry D., Manjili, Masoud H.
Pubblicato in J Leukoc Biol (2016)

EXOSOMES PRODUCED BY MESENCHYMAL STEM CELLS DRIVE DIFFERENTIATION OF MYELOID CELLS INTO IMMUNOSUPPRESSIVE M2-POLARIZED MACROPHAGES IN BREAST CANCER

di Biswas, Subir, Mandal, Gunjan, Chowdhury, Sougata Roy, Purohit, Suman, Payne, Kyle K., Anadon, Carmen, Gupta, Arnab, Swanson, Patricia, Yu, Xiaoqing, Conejo-Garcia, José R., Bhattacharyya, Arindam
Pubblicato in J Immunol (2019)

Tumor escape and progression of HER-2/neu negative breast cancer under immune pressure

di Kmieciak, Maciej, Payne, Kyle K, Idowu, Michael O, Grimes, Margaret M, Graham, Laura, Ascierto, Maria-Libera, Wang, Ena, Wang, Xiang-Yang, Bear, Harry D, Manjili, Masoud H
Pubblicazione 2011

Gr1(−/low)CD11b(−/low)MHCII(+) myeloid cells boost T cell anti‐tumor efficacy

di Payne, Kyle K., Aqbi, Hussein F., Butler, Savannah E., Graham, Laura, Keim, Rebecca C., Wan, Wen, Idowu, Michael O., Bear, Harry D., Wang, Xiang‐Yang, Manjili, Masoud H.
Pubblicato in J Leukoc Biol (2018)

IL-33 delays metastatic peritoneal cancer progression inducing an allergic microenvironment

di Perales-Puchalt, Alfredo, Svoronos, Nikolaos, Villarreal, Daniel O., Zankharia, Urvi, Reuschel, Emma, Wojtak, Krzysztof, Payne, Kyle K., Duperret, Elizabeth K., Muthumani, Kar, Conejo-Garcia, Jose R., Weiner, David B.
Pubblicato in Oncoimmunology (2018)

TRAMETINIB DRIVES T CELL-DEPENDENT CONTROL OF K-RAS-MUTATED TUMORS BY INHIBITING PATHOLOGICAL MYELOPOIESIS

di Allegrezza, Michael J., Rutkowski, Melanie R., Stephen, Tom L., Svoronos, Nikolaos, Perales-Puchalt, Alfredo, Nguyen, Jenny M., Payne, Kyle K., Singhal, Sunil, Eruslanov, Evgeniy B., Tchou, Julia, Conejo-Garcia, Jose R.
Pubblicato in Cancer Res (2016)